Proto Axiom

Venture capital fund
·
Sydney

About

Proto Axiom is a Sydney-based venture capital fund, founded in 2021, investing from seed through to Series A and Series B and beyond. Its recent deals are concentrated in life sciences and biotech, and it operates a company-creation model, building the companies it invests in using permanent capital and running the related Women's Health Foundry. Recent investments include AdvanCell Isotopes and JumpStart Fertility.

Written and verified by Cut Through Venture.

October 7, 2026

At a glance

Fund type
Venture capital fund
Headquarters
Sydney
Primary stage
Seed

Example portfolio companies

AdvanCell Isotopes JumpStart Fertility Endo Axiom

Source, Cut Through Venture deal tracker.

University of New South Wales

Sydney

University of New South Wales is a university-linked investor based in Sydney, backing companies from seed through accelerator, Series A and Series B+ stages via its Barker Street Ventures platform. Over the past decade, UNSW-linked ventures have attracted a cumulative $5.6 billion in capital, with deals spanning marketplaces, vertical and horizontal business software and hardware and robotics. Recent investments include High Earth Orbit Robotics and JumpStart Fertility.

View profile

Tin Alley Ventures

Melbourne

Tin Alley Ventures is a university-linked venture fund based in Melbourne, investing from seed through to accelerator and Series B+ stages. Created by the University of Melbourne with Tanarra Capital, it manages $125 million backing deep tech spinouts across horizontal business software, climate and energy, life sciences and biotech and AI infrastructure. Recent investments include Apromore and Proxima Bio.

View profile

Tenmile

Perth

Tenmile is a venture capital fund based in Perth, investing from seed through Series A and Series B+ rounds. Launched by Andrew Forrest's Tattarang in 2022 with $250 million in committed capital, it backs health technology companies across life sciences and biotech and healthtech. Recent investments include AdvanCell and Mindset Health.

View profile

Significant Capital Ventures

Canberra

Significant Capital Ventures is a venture capital fund based in Canberra, investing since 2000 at seed through Series B+ stages. It focuses on critical and applied technologies spanning climate and energy, healthtech, space and defence and hardware, robotics and sensors, with 32 investments across 3 funds and 21 SPV syndicates. Recent investments include Liquid Instruments and Visionary Machines.

View profile

InterValley Ventures

Sydney

InterValley Ventures is a venture capital fund based in Sydney, founded in 2019 and backing seed through Series B companies. It invests across life sciences, hardware and robotics, cybersecurity and consumer tech, and is affiliated with Mizuho Financial Group to help portfolio companies expand into Japan. Recent investments include QuintessenceLabs and Quantum Brilliance.

View profile

Brandon Capital

Melbourne

Brandon Capital is a Melbourne-based venture capital fund that invests from seed through to growth rounds. Founded by Chris Nave and Stephen Thompson, it focuses on life sciences and biotech, healthtech and consumer tech, and closed its Fund Six at more than $430 million in 2025 with a $150 million commitment from the National Reconstruction Fund Corporation. Recent investments include AdvanCell Isotopes and Lumonus.

View profile

Find more active investors

Browse the full list of Australian startup investors, or filter by stage and sector to find the right fit.

Browse the full investor database